- Oral presentation
- Open Access
- Published:
Two types of human Th17 cells with pro- and anti-inflammatory properties and distinct roles in autoinflammation
Pediatric Rheumatology volume 13, Article number: O49 (2015)
Introduction
Th17 cells are known to be crucial mediators of autoimmune inflammation. However, two distinct types of Th17 cells have recently been described, which differed in their ability to coproduce IL-10 or IFN-g due to differential polarizations requirements for IL-1b. Whether these distinct Th17 phenotypes translate into distinct Th17 cell functions and whether this has implications for human health or disease has not been addressed yet.
Objectives
We hypothesized that IL-1b independent IL-10+Th17 cells have anti-inflammatory functions whereas IL-1b dependent IL-10- Th17 cells are pro-inflammatory. Considering the crucial role of IL-1b in the pathogenesis of autoinflammatory syndromes, we hypothesized an IL-1b mediated loss of anti-inflammatory Th17 cell functions in Schnitzler Syndrome, an autoinflammatory disease.
Methods
To assess pro- versus anti-inflammatory Th17 cell functions we performed suppression assays and tested the effects of IL-1b dependent and independent Th17 subsets on modulating pro-inflammatory cytokine secretion by monocytes. Schnitzler Syndrome patients were analyzed for changes in Th17 cell functions before and after therapy with IL-1b depleting drugs.
Results
IL-10+ Th17 cells, which differentiated independently of IL-1b, have regulatory functions similar to Treg cells while IL-1b dependent IL-10- Th17 cells have not. Both Th17 cell subsets differ in their ability to suppress T cell proliferation as well as in their ability modulate pro-inflammatory cytokine production by antigen presenting cells. In Schnitzler Syndrome, an autoinflammatory syndrome, overproduction of IL-1b translates into pro-inflammatory Th17 cell functions, which can be reversed by anti-IL-1b treatment.
Conclusion
Th17 cells are not per se pro-inflammatory but can also have anti-inflammatory IL-10 mediated functions if generated independently of IL-1b. Our data introduce Th17 cell subsets as novel players in autoinflammation and thus novel therapeutic targets in autoinflammatory syndromes including other IL-1b mediated diseases. This demonstrates for the first time alterations in the adaptive immune system in autoinflammatory syndromes.
Author information
Authors and Affiliations
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Noster, R., de Koning, H., Sallusto, F. et al. Two types of human Th17 cells with pro- and anti-inflammatory properties and distinct roles in autoinflammation. Pediatr Rheumatol 13 (Suppl 1), O49 (2015). https://doi.org/10.1186/1546-0096-13-S1-O49
Published:
DOI: https://doi.org/10.1186/1546-0096-13-S1-O49
Keywords
- Th17 Cell
- Treg Cell
- Autoinflammatory Disease
- Th17 Subset
- Autoinflammatory Syndrome